Chugai Pharmaceutical Co. Ltd Financials

Market Capitalization ¥11.542 Trillion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	28.18
Forward PE	29.73
Price to Sales TTM	¥9.44
Price to Book MRQ	¥6.05
Enterprise to Revenue	9.36
Enterprise to EBITDA	18.90

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-06-30
Profit Margin	33.56%
Operating Margin	47.37%
Return on Assets TTM	17.92%
Return on Equity TTM	23.11%

Income Statement

Revenue TTM	¥1,222,120,964,096
Revenue per Share TTM	¥742.71
Quarterly Revenue Growth	21.70%
Gross Profit TTM	¥867,838,984,192
EBITDA	¥488,374,000,000
Net Income to Common TTM	¥410,150,010,880
Diluted EPS TTM	¥248.89
Quarterly Earnings Growth YoY	30.70%

Balance Sheet

Total Cash MRQ	¥944,549,986,304
Total Cash per Share MRQ	¥573.98
Total Debt MRQ	¥
Total Debt to Equity MRQ	0.00
Current Ratio MRQ	7.28
Book Value per Share MRQ	¥1158.97

Cash Flow

Operating Cash Flow TTM	¥413,363,994,624
Levered Free Cash Flow TTM	¥286,453,497,856

4519 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,645,525,803
Float Shares	639,683,476
Avg 10 Volume	1,935,850
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	59.91%
% Held by Institutions	18.57%

Stock Price Summary

Beta	0.67
Fifty Two Week Low	¥5806.00
Fifty Two Week High	¥8655.00
Fifty Two Week Change	13.08%
Day 50 MA	¥7695.46
Day 200 MA	¥7142.84

Dividends and Splits

Forward Annual Dividend Rate	¥100.00
Forward Annual Dividend Yield	1.40%
Trailing Annual Dividend Rate	¥91.00
Trailing Annual Dividend Yield	1.28%
Payout Ratio	39.32%
Dividend Date
Ex Dividend Date	2025-12-29
Last Split Factor
Last Split Date	2020-06-29